Drugs / bromodeoxyuridine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003832 | Jul 1999 → Jun 2002 | prostate carcinoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003405 Background | Apr 1998 → Apr 1999 | leukemia | Rush University Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bromodeoxyuridine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003832 ↗ |
| Route | Intravenous | “broxuridine IV over 60 minutes” NCT00003405 ↗ |